Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04957992 · ClinicalTrials.gov registry record · NA
BIG Study (Brain, Immune, and Gut Health Evaluation of Infants/Young Children Fed Infant Formula, and Later Supplemental Toddler Nutrition, With 5 Specific HMOs)
A NA study, sponsored by Abbott Nutrition.
- Completed
- Registry status
- NA
- Development phase
- 607
- Enrollment target
NCT04957992 is a NA study that has completed, run by Abbott Nutrition. The registered enrollment target is 607 participants.
The verdict
NCT04957992, a NA study, has completed, sponsored by Abbott Nutrition.
- COMPLETED
- Registry status
- NA
- Development phase
- 607 participants
- Enrollment target
Study Summary
The purpose of this study is to evaluate the growth and development outcomes of infants fed a new infant formula and toddler drink through 24 months of age.
Interventions
- OTHER Experimental Infant Formula
- OTHER Control Infant Formula
- OTHER Control Toddler Drink
- OTHER Experimental Toddler Drink
- OTHER Human Milk
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 607 participants |
| Start Date | 2021-07-21 |
| Est. Completion | 2025-05-12 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04957992
The ClinicalTrials.gov registry entry for NCT04957992 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 607 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Abbott Nutrition, which has 89 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 5 interventions - of which Experimental Infant Formula is the first listed.
NCT04957992 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04957992 about?
NCT04957992 is a clinical study titled "BIG Study (Brain, Immune, and Gut Health Evaluation of Infants/Young Children Fed Infant Formula, and Later Supplemental Toddler Nutrition, With 5 Specific HMOs)". The purpose of this study is to evaluate the growth and development outcomes of infants fed a new infant formula and toddler drink through 24 months of age.
What is the current status of trial NCT04957992?
This trial is currently completed. It is a NA study. The enrollment target is 607 participants. The study started on 2021-07-21. Estimated completion is 2025-05-12.
What interventions are being tested in trial NCT04957992?
The interventions under investigation include: Experimental Infant Formula (OTHER), Control Infant Formula (OTHER), Control Toddler Drink (OTHER), Experimental Toddler Drink (OTHER), Human Milk (OTHER).
Who is sponsoring clinical trial NCT04957992?
This trial is sponsored by Abbott Nutrition, which has 89 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.